← brief for 2026-10-03 · Slowing decline

Unraveling cardiac amyloidosis in Egypt: diagnostic challenges and disease outcomes.

Key takeaways

This study describes how a heart disease called amyloidosis looks in patients in Egypt. It is an observational study, so it shows a link, not proof of cause.

Who did this work

Abayazeed RM (Cardiology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt. [email protected].) · Etman I (Cardiology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.) · Hassanein M (Cardiology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.) · Kamal HM (Cardiology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.) · Elsakhawy M (Cardiology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.) · Abdelaaty A (Cardiology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.) · Allam M (Pathology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.) · Soror N (Hematology Unit, Department of Internal Medicine, Alexandria University, Alexandria, Egypt.) · Elghandour A (Hematology Unit, Department of Internal Medicine, Alexandria University, Alexandria, Egypt.) · Elbahoty MH (Hematology Unit, Department of Internal Medicine, Alexandria University, Alexandria, Egypt.) · Salama S (Department of Neurology, Alexandria University, Alexandria, Egypt.) · Refai OM (Nephrology Unit, Department of Internal Medicine, Alexandria University, Alexandria, Egypt.)

Source

Article · Europe PMC, CKD · 2026-09-29
https://doi.org/10.1186/s43044-026-00784-x